Richard J. Daly

Richard J. Daly is a declared insider at 5 companies (chief executive); the most frequent names are Broadridge Financial Solutions, Inc., Catalyst Pharmaceuticals, Inc. and Palisade Bio, Inc. The record holds 136 filings, for trades running from 17 February 2016 to 15 July 2026.

Both buying and selling appear: 8 purchases worth €105k, against 45 sales worth €165.9M. The net balance comes to €165.7M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 25 share grants and 47 option exercises.

The median purchase comes to €9,459. 2 out of 8 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The latest filing, published on 17 July 2026, reports a transaction of €7.5M in Catalyst Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 2,423 days ago, on 2 March 2020. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.